Kristen Williams - Feb 1, 2025 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Administrative Officer
Signature
/s/ Kristen Williams
Stock symbol
PCRX
Transactions as of
Feb 1, 2025
Transactions value $
$0
Form type
4
Date filed
2/4/2025, 06:25 PM
Previous filing
Jun 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Award $0 +79.2K +76.96% $0.00 182K Feb 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.